The overall data, however, established a clear positive correlation between WAVE3 expression levels in the primary tumors and severe/adverse disease characteristics, and, led us, therefore to speculate that increased WAVE3 expression levels in the primary tumors may be in part the main driving force behind the progression of breast cancer to more aggressive stages. This evidence concerns the gene WASF3 and breast carcinoma.